Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “CTOR”

756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 756
Index total 30,257
Page 14 / 32

Quick answer

This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

756 results for “CTOR” · 30,257 patents in full index Clear search

  1. US 10001495

    Blood factor monitoring assay and uses thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jun 19, 2018 · Expires Jun 14, 2038

    granted

  2. US 9975926

    Methods of making and using vaccines utilizing minicircle DNA expression vectors for production of foot-and-mouth-disease virus proteins and virus-like particles

    The United States of America, as represented by the Secretary of Homeland Security · Granted May 22, 2018 · Expires May 17, 2038

    granted

  3. US 9970059

    Survival predictor for diffuse large B cell lymphoma

    The United States of America, as Represented by the Secretary, Department of Human Services · Granted May 15, 2018 · Expires May 10, 2038

    granted

  4. US 9962370

    Methods of treatment associated with the granulocyte colony-stimulating factor receptor

    Ligand Pharmaceuticals Incorporated · Granted May 8, 2018 · Expires May 3, 2038

    granted

  5. US 9957327

    Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Five Prime Therapeutics, Inc. · Granted May 1, 2018 · Expires Apr 26, 2038

    granted

  6. US 9957329

    Factor XII inhibitors for the treatment of neurological inflammatory disorders

    Julius-Maximilians-Universitat Wurzburg · Granted May 1, 2018 · Expires Apr 26, 2038

    granted

  7. US 9938272

    Hydrazine compound as blood coagulation factor Xa inhibitor

    North China Pharmaceutical Company., Ltd. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  8. US 9932564

    Recombinant isfahan viral vectors

    The Board of Regents of the University of Texas System · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted

  9. US 9920297

    Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene WT1

    Vaximm AG · Granted Mar 20, 2018 · Expires Mar 15, 2038

    granted

  10. US 9890369

    Cytolethal distending toxin subunit B conjugated or fused to Bacillus anthracis toxin lethal factor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  11. US 9889211

    Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Feb 13, 2018 · Expires Feb 8, 2038

    granted

  12. US 9867845

    Vectors for delivery of agents across biological membranes

    The Regents of the University of California · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  13. US 9867873

    Factor IX polypeptides and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  14. US 9856467

    Modified factor X polypeptides and uses thereof

    Catalyst Biosciences, Inc. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  15. US 9827272

    Growth factor sequestering and presenting hydrogels

    The Regents of the University of California · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted

  16. US 9801938

    Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists

    FREISTAAT BAYERN REPRESENTED BY JULIUS-MAXIMILLIANS-UNIVERSITÄT WÜRZBURG · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  17. US 9803205

    Compositions and methods for inhibiting gene expression of factor XII

    Arrowhead Pharmaceuticals, Inc. · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  18. US 9790272

    Stem cell factor inhibitor

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  19. US 9789144

    Inhibition of hypoxia-inducible factor activity with Carica papaya extracts

    The Regents of the University of California · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  20. US 9758775

    TAL effector-mediated DNA modification

    Regents of the University of Minnesota · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted

  21. US 9758556

    Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

    The Regents of the University of California · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted

  22. US 9758555

    Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

    The Regents of the University of California · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted

  23. US 9732359

    Replication-competent adenoviral vectors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted

  24. US 9724387

    Administration of growth factors for the treatment of CNS disorders

    The Regents of the University of California · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.